References
- KearneyPMWheltonMReynoldsKMuntnerPWheltonPKHeJGlobal burden of hypertension: analysis of worldwide dataLancet2005365945521722315652604
- FranklinSSLarsonMGKhanSADoes the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart StudyCirculation20011031245124911238268
- World Health OrganizationWorld Health Statistics. A Snapshot of Global HealthGenevaWorld Health Organization2012 Available from: http://apps.who.int/iris/bitstream/10665/70889/1/WHO_IER_HSI_12.1_eng.pdfAccessed June 23, 2014
- GoASMozaffarianDRogerVLHeart disease and stroke statistics – 2013 update: a report from the American Heart AssociationCirculation2013127e6e24523239837
- DubeyRKOparilSImthurnBJacksonEKSex hormones and hypertensionCardiovasc Res200253368870811861040
- StaessenJBulpittCJFagardRLijnenPAmeryAThe influence of menopause on blood pressureJ Hum Hypertens1989364274332607517
- ScuteriABosAJBrantLJTalbotLLakattaEGFlegJLHormone replacement therapy and longitudinal changes in blood pressure in postmenopausal womenAnn Intern Med2001135422923811511137
- AmigoniSMorelliPParazziniFChatenoudLDeterminants of elevated blood pressure in women around menopause: results from a cross-sectional study in ItalyMaturitas2000341253210687879
- ZanchettiAFacchettiRCesanaGCModenaMGPirrelliASegaRMenopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological studyJ Hypertens200523122269227616269969
- CifkovaRPithaJLejskovaMLanskaVZecovaSBlood pressure around the menopause: a population studyJ Hypertens200826101976198218806621
- CagnacciAZaninRCannolettaMGeneraliMCarettoSVolpeAMenopause, estrogens, progestins, or their combination on body weight and anthropometric measuresFertil Steril20078861603160817481628
- CagnacciACannolettaMPalmaFZaninRXholliAVolpeAMenopausal symptoms and risk factors for cardiovascular disease in postmenopauseClimacteric201215215716222141325
- TothMJTchernofASitesCKPoehlmanETEffect of menopausal status on body composition and abdominal fat distributionInt J Obes Relat Metab Disord200024222623110702775
- CasigliaEd’EsteDGinocchioGLack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 womenJ Hypertens19961467297368793695
- LeeJSHayashiKMishraGYasuiTKubotaTMizunumaHIndependent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses’ health studyJ Atheroscler Thromb201320216116923079582
- CasigliaETikhonoffVCaffiSMenopause does not affect blood pressure and risk profile, and menopausal women do not become similar to menJ Hypertens200826101983199218806622
- VegetoEBelcreditoSEtteriSEstrogen receptor-alpha mediates the brain antiinflammatory activity of estradiolProc Natl Acad Sci U S A2003100169614961912878732
- DarbladeBPendariesCKrustAEstradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptorCirc Res200290441341911884370
- GearyGGMcNeillAMOspinaJAKrauseDNKorachKSDucklesSPSelected contribution: cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alphaJ Appl Physiol20019152391239911641386
- ChakrabartiSMortonJSDavidgeSTMechanisms of estrogen effects on the endothelium: an overviewCan J Cardiol201430770571224252499
- GustafssonJÅWhat pharmacologists can learn from recent advances in estrogen signallingTrends Pharmacol Sci200324947948512967773
- CruzMNAgewallSSchenck-GustafssonKKublickieneKAcute dilatation to phytoestrogens and estrogen receptor subtypes expression in small arteries from women with coronary heart diseaseAtherosclerosis20081961495817367797
- WellmanGCBonevADNelsonMTBraydenJEGender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channelsCirc Res1996795102410308888695
- FreayADCurtisSWKorachKSRubanyiGMMechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta. Role of nuclear estrogen receptor and Ca2+ uptakeCirc Res19978122422489242185
- CrewsKKhalilRAGender-specific inhibition of Ca2+ entry mechanisms of arterial vasoconstriction by sex hormonesClin Exp Pharmacol Physiol199926970771510499160
- WennerMMStachenfeldNSBlood pressure and water regulation: understanding sex hormone effects within and between men and womenJ Physiol2012590Pt 235949596123027816
- WassmannKWassmannSNickenigGProgesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and functionCirc Res200597101046105416195479
- PinesAFismanEZDroryYThe effects of sublingual estradiol on left ventricular function at rest and exercise in postmenopausal women: an echocardiographic assessmentMenopause19985279859689200
- ReisSEGlotheSTBlumenthalRSEthinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal womenCirculation199489152608281693
- GilliganDMBadarDMPanzaJAQuyyumiAACannonROAcute vascular effects of estrogen in postmenopausal womenCirculation19949027867918044949
- VolterraniMRosanoGCoatsABealeCCollinsPEstrogen acutely increases peripheral blood flow in postmenopausal womenAm J Med19959921191227625415
- TagawaHShimokawaHTagawaTKuroiwa–MatsumotoMHirookaYTakeshitaAShort-term estrogen augments both nitric oxide-mediated and nonnitric oxide-mediated endothelium-dependent forearm vasodilation in postmenopausal womenJ Cardiovasc Pharmacol19973044814889335408
- Al-KhaliliFErikssonMLandgrenBMSchenk–GustafssonKEffect of conjugated estrogen on peripheral flow-mediated vasodilation in postmenopausal womenAm J Cardiol19988222152189678294
- CicconeMMScicchitanoPGesualdoMSystemic vascular hemodynamic changes due to 17-β-estradiol intranasal administrationJ Cardiovasc Pharmacol Ther201318435435823624711
- LiebermanEHGerhardMDUehataAEstrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal womenAnn Intern Med1994121129369417978718
- BushDEJonesCEBassKMWaltersGKBruzaJMOuyangPEstrogen replacement reverses endothelial dysfunction in postmenopausal womenAm J Med199810465525589674718
- GerhardMWalshBWTawakolAEstradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal womenCirculation19989812115811639743505
- PintoSVirdisAGhiadonoLEndogenous estrogen and acetylcholine-induced vasodilation in normotensive womenHypertension1997291 Pt 22682639039113
- SorensenKEDorupIHermannAPMosekildeLCombined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor functionCirculation19989713123412389570192
- CagnacciAModenaMGMalmusiSMuiaNVolpeAEffect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal womenAm J Cardiol199984336737010496459
- OnedaBCardosoCGJrForiazCLEffects of estrogen therapy and aerobic training on sympathetic activity and hemodynamics in healthy postmenopausal women: a double-blind randomized trialMenopause201421436937523899829
- NovellaSDantasAPSegarraGGathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated miceExp Gerontol2010451186887420708673
- BestPJBergerPBMillerVMLermanAThe effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal womenAnn Intern Med199812842852889471931
- ImthurnBRosselliMJaegerAWKellerPJDubeyRKDifferential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetateJ Clin Endocrinol Metab19978223883949024224
- RosselliMImthurnBKellerPJJacksonEKDubeyRKCirculating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up studyHypertension1995254 Pt 28488537721443
- YlikorkalaOCacciatoreBPaakkariITikkanenMJViinikkaLToivonenJThe long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxaneFertil Steril19986958838889591497
- ViinikkaLOrpanaAPuolakkaJPyöräläTYlikorkalaODifferent effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2Obstet Gynecol19978911041078990448
- MoreyAKRazandiMPedramAHuRMPrinsBALevinEROestrogen and progesterone inhibit the stimulated production of endothelin-1Biochem J1998330Pt 3109711059494073
- ReckelhoffJFFortepianiLANovel mechanisms responsible for postmenopausal hypertensionHypertension200443591892315023933
- DubeyRKOparilSImthurnBJacksonEKSex hormones and hypertensionCardiovasc Res200253368870811861040
- SchunkertHDanserAHHenseHWDerkxFHKurzingerSRieggerGAEffects of estrogen replacement therapy on the renin–angiotensin system in postmenopausal womenCirculation199795139458994414
- YlikorkalaOOrpanaAPuolakkaJPyöräläTViinikkaLPostmenopausal hormonal replacement decreases plasma levels of endothelin-1J Clin Endocrinol Metab19958011338433877593457
- NickenigGBaumerATGroheCEstrogen modulates AT1 receptor gene expression in vitro and in vivoCirculation19989722219730019631868
- MenozziRCagnacciAZanniALBondiMVolpeADel RioGSympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiolMaturitas200034327528110717494
- CagnacciAZanniALVeneriMGMenozziRVolpeADel RioGInfluence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacementClin Endocrinol (Oxf)200053336737210971455
- PimientaEHypertension in womenHypertension Research201235214815222129517
- FungMMPoddarSBettencourtRJassalSKBarrett-ConnorEA cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo StudyMenopause201118662963721326121
- AndersonGLLimacherMAssafAREffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trialJAMA2004291141701171215082697
- WrenBGRoutledgeDABlood pressure changes: oestrogens in climacteric womenMed J Aust19812105285316275247
- WrenBGRoutledgeADThe effect of type and dose of oestrogen on the blood pressure of post-menopausal womenMaturitas1983521351426314097
- SteinerAZHodisHNLoboRAShoupeDXiangMMackWJPostmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis TrialMenopause200512672873316278616
- CardosoCGJrRosasFCOnedaBAerobic training abolishes ambulatory blood pressure increase induced by estrogen therapy: a double blind randomized clinical trialMaturitas201169218919421493022
- AkkadAAHalliganAWAbramsKal-AzzawiFDiffering responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapyObstet Gynecol1997891971038990447
- VongpatanasinWTuncelMMansourYArbiqueDVictorRGTransdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal womenCirculation2001103242903290811413078
- CagnacciARovatiLZanniAMalmusiSFacchinettiFVolpeAPhysiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal womenAm J Physiol19992764 Pt 2H1355H136010199862
- DriulLStellaAMarchesoniDTwenty-four hour ambulatory blood pressure in postmenopausal smokers and non-smokers on hormone therapyInt J Gynaecol Obstet2005901828315913624
- WindlerEZyriaxBCEidenmüllerBBoeingHHormone replacement therapy and risk for coronary heart disease. Data from the CORA-study – A case-control study on women with incident coronary heart diseaseMaturitas200757323924617292571
- ScuteriABosAJBrantLJTalbotLLakattaEGFlegJLHormone replacement therapy and longitudinal changes in blood pressure in postmenopausal womenAnn Intern Med200121135422923811511137
- HassagerCChristiansenCBlood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal womenMaturitas1988943153233288846
- The Writing Group for the PEPI TrialEffects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) TrialJAMA199527331992087807658
- VestergaardPHermannAPStilgrenLEffects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure – a randomised controlled studyMaturitas200346212313214559383
- ChiuCLLujicSThorntonCMenopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort studyPLoS One Epub7112012
- Wassertheil-SmollerSAndersonGPsatyBMHypertension and its treatment in postmenopausal women: baseline data from the Women’s Health InitiativeHypertension200036578078911082143
- GradyDHerringtonDBittnerRCardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study follow-up (HERS II)JAMA20022881495712090862
- van IttersumFJvan BaalWMKenemansPAmbulatory – not office – blood pressures decline during hormone replacement therapy in healthy postmenopausal womenAm J Hypertens19981110114711529799030
- HarveyPJWingLMSavageJMolloyDThe effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin–angiotensin system in normotensive postmenopausal womenJ Hypertens199917340541110100079
- SørensenMBRasmussenVJensenGOttesenBTemporal changes in clinic and ambulatory blood pressure during cyclic postmenopausal hormone replacement therapyJ Hypertens200018101387139111057425
- ManwaringPMorfisLDiamondTHowesLGEffects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive womenBlood Press200091222710854004
- CacciatoreBPaakkariIHasselblattRRandomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal womenAm J Obstet Gynecol2001184590490911303197
- PaakariIHasselblattRNieminenMSComparison of the effect of transdermal and oral HRT on ambulatory blood pressure in postmenopausal womenMaturitas199727100198
- PrippUHallGCsemiczkyGEksborgSLandgrenBMSchenck-GustafssonKA randomized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery diseaseJ Hypertens199917101379138610526897
- ZacharievaSKirilovGKalinovKEffect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal womenGynecol Endocrinol200216646146712626033
- SeelyEWWalshBWGerhardMDWilliamsGHEstradiol with or without progesterone and ambulatory blood pressure in postmenopausal womenHypertension19993351190119410334810
- SeegerHMueckAOTeichmannATLippertTHEffect of sequential estrogen/progestin treatment on biochemical vasoactive markers in postmenopausal women comparing oral and transdermal applicationClin Exp Obstet Gynecol2000271172010758791
- KuhlHVascular effects of gestagens – biochemistry versus epidemiologyZentralbl Gynakol199912126778 German [with English abstract]10096172
- RylancePBBrincatMLaffertyKNatural progesterone and antihypertensive actionBr Med J1985290646113143917316
- DeuringerFUMueckAOMueckSSeegerHWallwienerDProgestin effect on blood pressure during combination with transdermal estradiol – chlormadinone acetate vs norethisterone acetateAsoTYanaiharaTTaketaniYSudaTTanakaHMaeharaSNinth International Menopause Society World Congress on the MenopauseBolognaMonduzzi Editore S.p.A2000177181
- MueckAOSeegerHGräserTDeuringerFUOettelMLippertTHChlormadinone acetate vs norethisterone acetate sequentially combined with oral or transdermal estradiol replacementNS Arch Pharmacol Toxicol1997356R5R6
- MueckAOGräserTSeegerHIs there a dose-dependent effect of dienogest, continuously combined with estradiol valerate, on blood pressure?Experimental and Clinical Endocrinol Diabetes19981061S36
- MueckAOSeegerHLüdtkeRGräserTWallwienerDEffect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol vs estradiol/dienogestMaturitas200138330531311358648
- van der MoorenMJThe influence of postmenopausal oestradiol-dydrogesterone therapy on blood pressureMaturitas199627Suppl 199100
- KesselHKampOKenemansPEffects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal womenAm J Obstet Gynecol2001184591091611303198
- HarveyPJMolloyDUptonJWingLMDose response effect of cyclical medroxyprogesterone on blood pressure in postmenopausal womenJ Hum Hypertens200115531332111378833
- ArcherDFDrospirenone, a progestin with added value for hypertensive postmenopausal womenMenopause2007143 Pt 135235417414576
- WhiteWBPittBPrestonRAHanesVAntihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertensionCirculation2005112131979198416186434
- WhiteWBHanesVChauhanVPittBEffects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertensionHypertension200648224625316801478
- WhiteWBHanesVMallareddyMChauhanVEffects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertensionJ Am Soc Hypertens200821202720409881
- GambaccianiMRosanoGCappagliBPepeAVitaleCGenazzaniARClinical and metabolic effects of drospirenone-estradiol in menopausal women: a prospective studyClimacteric2011141182420979461
- BattagliaCCianciosiAManciniFAngeliq versus Activelle in normotensive postmenopausal women: a prospective, randomized pilot studyMenopause200916480380919194341
- LuotolaHBlood pressure and hemodynamics in postmenopausal women during estradiol-17 beta substitutionAnn Clin Res198315Suppl 3811216367617
- MercuroGZoncuSPianoDEstradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertensionAm J Hypertens1998118 Pt 19099139715781
- MueckAOSeegerHEffect of hormone therapy on BP in normotensive and hypertensive postmenopausal womenMaturitas200449318920315488347
- de AloysioDGambaccianiMMeschiaMThe effect of menopause on blood lipid and lipoprotein levels. The Icarus Study GroupAtherosclerosis1999147114715310525136
- KornhauserCMalacaraJMGarayMEPérez-LuqueELThe effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertensionJ Hum Hypertens19971174054119283055
- JespersenCMArnungKHagenCEffects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal womenJ Hypertens1983143613646442719
- HarveyPJMolloyDUptonJWingLMDose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertensionBlood Press20009527528211193131
- MueckAODeuringerFUSeegerHWallwienerDTransdermal estradiol/oral progestin: blood pressure in 13910 patientsMaturitas200035S63
- FoidartJMEffects of estraderm TTS 50 plus medroxyprogesterone acetate on blood pressure in hypertensive postmenopausal womenSamsioeGCardiovascular Disease and HRTNew Perspectives. UKParthenon19914144
- SuminoHIchikawaSKumakuraHEffects of hormone replacement therapies on office and ambulatory blood pressure in Japanese hypertensive postmenopausal womenHypertens Res200326536937612887127
- KayaCDinçer CengizSCengizBAkgünGThe long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective studyClimacteric20069643744517085376
- WongJWongSHandaPAbbottCHormone replacement use, arterial distensibility, cardiac structure and circadian blood pressure profile in menopausal womenBlood Press2005141122015823942
- AffinitoPPalombaSBonifacioMEffects of hormonal replacement therapy in postmenopausal hypertensive patientsMaturitas2001401758311684376
- SchulmanIHArandaPRaijLVeronesiMArandaFJMartinRSurgical menopause increases salt sensitivity of blood pressureHypertension20064761168117416618835
- SzekacsBVajoZAcsNHormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertensionMenopause200071313510646701
- PrestonRAAlonsoAPanzittaDZhangPKararaAHAdditive effect of drospirenone/17-beta-estradiol in hypertensive postmenopausal women receiving enalaprilAm J Hypertens200215981682212219878
- PrestonRAComparative effects of conventional vs novel hormone replacement therapy on blood pressure in postmenopausal womenClimacteric200912Suppl 1667019811245